| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |